{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:19:51Z","timestamp":1787955591333,"version":"build-2784847793"},"reference-count":242,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-33\/2026-03\/200026"],"award-info":[{"award-number":["451-03-33\/2026-03\/200026"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Education, Science, and Innovation, Montenegro","award":["01-082\/22-1681\/3"],"award-info":[{"award-number":["01-082\/22-1681\/3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s12265-026-10820-5","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:50:24Z","timestamp":1787950224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Trajectory of Epigenetic Chromatin Remodeling in Cardiometabolic Disease and its Therapeutic Implications"],"prefix":"10.1007","volume":"19","author":[{"given":"Mirjana","family":"Macvanin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7870-0996","authenticated-orcid":false,"given":"Aleksandra","family":"Klisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"25","key":"10820_CR1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health. J Am Coll Cardiol. 2022;80(25):2361\u201371.","journal-title":"J Am Coll Cardiol"},{"key":"10820_CR2","doi-asserted-by":"publisher","unstructured":"Eroglu T, Capone F, Schiattarella GG. The evolving landscape of cardiometabolic disease. eBioMedicine. 2024;109. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105447.","DOI":"10.1016\/j.ebiom.2024.105447"},{"issue":"6","key":"10820_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/qjmed\/hcaf022","volume":"118","author":"SCW Tan","year":"2025","unstructured":"Tan SCW, Zheng BB, Tang ML, Chu H, Zhao YT, Weng C. Global Burden of Cardiovascular Diseases and its Risk Factors, 1990\u20132021: A Systematic Analysis for the Global Burden of Disease Study 2021. QJM. 2025;118(6):411\u201322.","journal-title":"QJM"},{"issue":"1","key":"10820_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41392-024-01918-w","volume":"9","author":"W Yao","year":"2024","unstructured":"Yao W, Hu X, Wang X. Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases. Signal Transduct Target Therapy. 2024;9(1):232.","journal-title":"Signal Transduct Target Therapy"},{"issue":"6648","key":"10820_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/38444","volume":"389","author":"K Luger","year":"1997","unstructured":"Luger K, M\u00e4der AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature. 1997;389(6648):251\u201360.","journal-title":"Nature"},{"issue":"7","key":"10820_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nrm3382","volume":"13","author":"K Luger","year":"2012","unstructured":"Luger K, Dechassa ML, Tremethick DJ. New insights into nucleosome and chromatin structure: an ordered state or a disordered affair? Nat Rev Mol Cell Biol. 2012;13(7):436\u201347.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10820_CR7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cell.2013.07.011","volume":"154","author":"GJ Narlikar","year":"2013","unstructured":"Narlikar GJ, Sundaramoorthy R, Owen-Hughes T. Mechanisms and functions of ATP-dependent chromatin-remodeling enzymes. Cell. 2013;154(3):490\u2013503.","journal-title":"Cell"},{"issue":"6","key":"10820_CR8","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.cell.2014.10.054","volume":"159","author":"HS Rhee","year":"2014","unstructured":"Rhee HS, Bataille AR, Zhang L, Pugh BF. Subnucleosomal structures and nucleosome asymmetry across a genome. Cell. 2014;159(6):1377\u201388.","journal-title":"Cell"},{"issue":"6765","key":"10820_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/47412","volume":"403","author":"BD Strahl","year":"2000","unstructured":"Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403(6765):41\u20135.","journal-title":"Nature"},{"issue":"1\u20132","key":"10820_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.mrrev.2008.02.004","volume":"659","author":"T Vaissi\u00e8re","year":"2008","unstructured":"Vaissi\u00e8re T, Sawan C, Herceg Z. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res. 2008;659(1\u20132):40\u20138.","journal-title":"Mutat Res"},{"issue":"1609","key":"10820_CR11","doi-asserted-by":"publisher","first-page":"20110332","DOI":"10.1098\/rstb.2011.0332","volume":"368","author":"C Huang","year":"2013","unstructured":"Huang C, Xu M, Zhu B. Epigenetic inheritance mediated by histone lysine methylation: maintaining transcriptional states without the precise restoration of marks? Philos Trans R Soc Lond B Biol Sci. 2013;368(1609):20110332.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"5","key":"10820_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrg3173","volume":"13","author":"EL Greer","year":"2012","unstructured":"Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet. 2012;13(5):343\u201357.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10820_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-022-01055-2","volume":"7","author":"Y Shi","year":"2022","unstructured":"Shi Y, Zhang H, Huang S, Yin L, Wang F, Luo P, et al. Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials. Signal Transduct Target Therapy. 2022;7(1):200.","journal-title":"Signal Transduct Target Therapy"},{"issue":"4","key":"10820_CR14","first-page":"277","volume":"2","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zhang M, Wang Y. The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy. J Natl Cancer Cent. 2022;2(4):277\u201390.","journal-title":"J Natl Cancer Cent"},{"issue":"2","key":"10820_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","volume":"52","author":"S-Y Park","year":"2020","unstructured":"Park S-Y, Kim J-S. A short guide to histone deacetylases including recent progress on class II enzymes. Exp Mol Med. 2020;52(2):204\u201312.","journal-title":"Exp Mol Med"},{"issue":"1\u20132","key":"10820_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1615\/CritRevOncog.2015012997","volume":"20","author":"HP Chen","year":"2015","unstructured":"Chen HP, Zhao YT, Zhao TC. Histone deacetylases and mechanisms of regulation of gene expression. Crit Rev Oncog. 2015;20(1\u20132):35\u201347.","journal-title":"Crit Rev Oncog"},{"key":"10820_CR17","doi-asserted-by":"publisher","first-page":"116696","DOI":"10.1016\/j.ejmech.2024.116696","volume":"276","author":"Z Huang","year":"2024","unstructured":"Huang Z, Zeng L, Cheng B, Li D. Overview of class I HDAC modulators: Inhibitors and degraders. Eur J Med Chem. 2024;276:116696.","journal-title":"Eur J Med Chem"},{"issue":"48","key":"10820_CR18","doi-asserted-by":"publisher","first-page":"E5178","DOI":"10.1073\/pnas.1415589111","volume":"111","author":"PM McLendon","year":"2014","unstructured":"McLendon PM, Ferguson BS, Osinska H, Bhuiyan MS, James J, McKinsey TA, et al. Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy. Proc Natl Acad Sci U S A. 2014;111(48):E5178\u201386.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5\u20136","key":"10820_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.vph.2011.07.001","volume":"55","author":"HJ Kee","year":"2011","unstructured":"Kee HJ, Kwon J-S, Shin S, Ahn Y, Jeong MH, Kook H. Trichostatin A prevents neointimal hyperplasia via activation of Kr\u00fcppel like factor 4. Vascul Pharmacol. 2011;55(5\u20136):127\u201334.","journal-title":"Vascul Pharmacol"},{"issue":"11","key":"10820_CR20","doi-asserted-by":"publisher","first-page":"5613","DOI":"10.1007\/s11010-025-05353-5","volume":"480","author":"P Pai","year":"2025","unstructured":"Pai P, D\u2019Mello RS, Brahme OM, Gogineni YV, Shetty MG, Sundara BK. Unlocking cardiac health: exploring the role of class I HDACs in cardiovascular diseases. Mol Cell Biochem. 2025;480(11):5613\u201337.","journal-title":"Mol Cell Biochem"},{"key":"10820_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev-pharmtox-010814-124527","volume":"55","author":"JJ Day","year":"2015","unstructured":"Day JJ, Kennedy AJ, Sweatt JD. DNA methylation and its implications and accessibility for neuropsychiatric therapeutics. Annu Rev Pharmacol Toxicol. 2015;55:591\u2013611.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10820_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2018.08.021","volume":"837","author":"S Biswas","year":"2018","unstructured":"Biswas S, Rao CM. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy. Eur J Pharmacol. 2018;837:8\u201324.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10820_CR23","doi-asserted-by":"publisher","first-page":"168394","DOI":"10.1016\/j.jmb.2023.168394","volume":"436","author":"BM Tibben","year":"2024","unstructured":"Tibben BM, Rothbart SB. Mechanisms of DNA Methylation Regulatory Function and Crosstalk with Histone Lysine Methylation. J Mol Biol. 2024;436(7):168394.","journal-title":"J Mol Biol"},{"key":"10820_CR24","doi-asserted-by":"publisher","unstructured":"Baccarelli AA, Ordov\u00e1s J. Epigenetics of early cardiometabolic disease: mechanisms and precision medicine. 2023;132(12):1648\u201362. https:\/\/doi.org\/10.1161\/CIRCRESAHA.123.322135.","DOI":"10.1161\/CIRCRESAHA.123.322135"},{"key":"10820_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.atherosclerosis.2018.09.029","volume":"281","author":"S Costantino","year":"2019","unstructured":"Costantino S, Mohammed SA, Ambrosini S, Paneni F. Epigenetic processing in cardiometabolic disease. Atherosclerosis. 2019;281:150\u20138.","journal-title":"Atherosclerosis"},{"issue":"2","key":"10820_CR26","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/ijms27020983","volume":"27","author":"E M\u0142ynarska","year":"2026","unstructured":"M\u0142ynarska E, Bojdo K, Bulicz A, Hossa K, Lisi\u0144ska W, Stasiak P, et al. Epigenetic Regulation and Molecular Mechanisms in Cardiovascular Diseases: A Review of Recent Advances and Therapeutic Implications. Int J Mol Sci. 2026;27(2):983.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"10820_CR27","doi-asserted-by":"publisher","first-page":"9949","DOI":"10.3390\/ijms22189949","volume":"22","author":"M Gharipour","year":"2021","unstructured":"Gharipour M, Mani A, Amini Baghbahadorani M. How Are Epigenetic Modifications Related to Cardiovascular Disease in Older Adults? Int J Mol Sci. 2021;22(18):9949.","journal-title":"Int J Mol Sci"},{"key":"10820_CR28","doi-asserted-by":"publisher","first-page":"3102737","DOI":"10.1155\/2017\/3102737","volume":"2017","author":"Z Wang","year":"2017","unstructured":"Wang Z, Wang D, Wang Y. Cigarette Smoking and Adipose Tissue: The Emerging Role in Progression of Atherosclerosis. Mediators Inflamm. 2017;2017:3102737.","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10820_CR29","doi-asserted-by":"publisher","first-page":"s366","DOI":"10.1080\/07315724.2007.10719625","volume":"26","author":"SM Shenouda","year":"2007","unstructured":"Shenouda SM, Vita JA. Effects of flavonoid-containing beverages and EGCG on endothelial function. J Am Coll Nutr. 2007;26(4):s366\u201372.","journal-title":"J Am Coll Nutr"},{"key":"10820_CR30","doi-asserted-by":"publisher","first-page":"111489","DOI":"10.1016\/j.cbi.2025.111489","volume":"413","author":"K Jomova","year":"2025","unstructured":"Jomova K, Alomar SY, Valko R, Liska J, Nepovimova E, Kuca K, et al. Flavonoids and their role in oxidative stress, inflammation, and human diseases. Chemico-Biol Interact. 2025;413:111489.","journal-title":"Chemico-Biol Interact"},{"issue":"20","key":"10820_CR31","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.3390\/ijms21207711","volume":"21","author":"S Feij\u00f3o-Band\u00edn","year":"2020","unstructured":"Feij\u00f3o-Band\u00edn S, Arag\u00f3n-Herrera A, Mora\u00f1a-Fern\u00e1ndez S, Anido-Varela L, Taraz\u00f3n E. Adipokines and Inflammation: Focus on Cardiovascular Diseases. Int J Mol Sci. 2020;21(20):7711.","journal-title":"Int J Mol Sci"},{"key":"10820_CR32","first-page":"100734","volume":"63","author":"V Ga\u0161p\u00e1rkov\u00e1","year":"2026","unstructured":"Ga\u0161p\u00e1rkov\u00e1 V, Tran BT, O\u0161\u0165\u00e1dal P, Lambert L, H\u00e1jek P, Kala P. Epicardial adipose tissue in coronary microvascular disease. Am Heart J Plus. 2026;63:100734.","journal-title":"Am Heart J Plus"},{"issue":"22","key":"10820_CR33","doi-asserted-by":"publisher","first-page":"14296","DOI":"10.3390\/ijms232214296","volume":"23","author":"R D\u2019Oria","year":"2022","unstructured":"D\u2019Oria R, Genchi VA. Impact of Dysfunctional Adipose Tissue Depots on the Cardiovascular System. Int J Mol Sci. 2022;23(22):14296.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10820_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s10020-024-00939-z","volume":"30","author":"G Damiano","year":"2024","unstructured":"Damiano G, Rinaldi R, Raucci A, Molinari C, Sforza A, Pirola S, et al. Epigenetic mechanisms in cardiovascular complications of diabetes: towards future therapies. Mol Med. 2024;30(1):161.","journal-title":"Mol Med"},{"key":"10820_CR35","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","volume":"50","author":"J Heeren","year":"2021","unstructured":"Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol metabolism. 2021;50:101238.","journal-title":"Mol metabolism"},{"issue":"8","key":"10820_CR36","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nm0898-934","volume":"4","author":"L Powell-Braxton","year":"1998","unstructured":"Powell-Braxton L, V\u00e9niant M, Latvala RD, Hirano KI, Won WB, Ross J, et al. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet. Nat Med. 1998;4(8):934\u20138.","journal-title":"Nat Med"},{"issue":"2","key":"10820_CR37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1161\/01.CIR.99.2.276","volume":"99","author":"E Lutgens","year":"1999","unstructured":"Lutgens E, Daemen M, Kockx M, Doevendans P, Hofker M, Havekes L, et al. Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage. Circulation. 1999;99(2):276\u201383.","journal-title":"Circulation"},{"key":"10820_CR38","doi-asserted-by":"publisher","first-page":"101728","DOI":"10.1016\/j.molmet.2023.101728","volume":"73","author":"G Mocciaro","year":"2023","unstructured":"Mocciaro G, Allison M, Jenkins B, Azzu V, Huang-Doran I, Herrera-Marcos LV, et al. Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL). Mol metabolism. 2023;73:101728.","journal-title":"Mol metabolism"},{"issue":"3","key":"10820_CR39","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1161\/ATVBAHA.122.318661","volume":"43","author":"KC Sung","year":"2023","unstructured":"Sung KC, Yoo TK. Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study. Arterioscler Thromb Vasc Biol. 2023;43(3):482\u201391.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10820_CR40","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0950-351X(96)80771-3","volume":"10","author":"MR Charlton","year":"1996","unstructured":"Charlton MR. Protein metabolism and liver disease. Bailliere\u2019s Clin Endocrinol metabolism. 1996;10(4):617\u201335.","journal-title":"Bailliere\u2019s Clin Endocrinol metabolism"},{"key":"10820_CR41","first-page":"309","volume":"1250","author":"S Heinz","year":"2015","unstructured":"Heinz S, Braspenning J. Measurement of Blood Coagulation Factor Synthesis in Cultures of Human Hepatocytes. (Clifton NJ). 2015;1250:309\u201316. Methods in molecular biology.","journal-title":"(Clifton NJ)"},{"issue":"2","key":"10820_CR42","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cmet.2018.10.013","volume":"29","author":"MD Neinast","year":"2019","unstructured":"Neinast MD, Jang C, Hui S, Murashige DS, Chu Q, Morscher RJ, et al. Quantitative Analysis of the Whole-Body Metabolic Fate of Branched-Chain Amino Acids. Cell Metabol. 2019;29(2):417\u2013. \u2013\u200929.e4.","journal-title":"Cell Metabol"},{"issue":"4","key":"10820_CR43","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ajpath.2023.12.006","volume":"194","author":"SK Anand","year":"2024","unstructured":"Anand SK, Governale TA, Zhang X, Razani B, Yurdagul A Jr., Pattillo CB, et al. Amino Acid Metabolism and Atherosclerotic Cardiovascular Disease. Am J Pathol. 2024;194(4):510\u201324.","journal-title":"Am J Pathol"},{"issue":"1","key":"10820_CR44","doi-asserted-by":"publisher","first-page":"25848","DOI":"10.1038\/s41598-024-76835-7","volume":"14","author":"L Prechtl","year":"2024","unstructured":"Prechtl L, Carrard J, Gallart-Ayala H, Borreggine R, Teav T, K\u00f6nigstein K, et al. Circulating amino acid signature features urea cycle alterations associated with coronary artery disease. Sci Rep. 2024;14(1):25848.","journal-title":"Sci Rep"},{"issue":"5","key":"10820_CR45","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1002\/ehf2.14872","volume":"11","author":"H Kouzu","year":"2024","unstructured":"Kouzu H, Yano T. Adverse plasma branched-chain amino acid profile mirrors fatty muscle degeneration in diabetic heart failure patients. ESC Heart Fail. 2024;11(5):2941\u201353.","journal-title":"ESC Heart Fail"},{"issue":"7","key":"10820_CR46","doi-asserted-by":"publisher","first-page":"e031617","DOI":"10.1161\/JAHA.123.031617","volume":"13","author":"KS Fine","year":"2024","unstructured":"Fine KS, Wilkins JT. Circulating Branched Chain Amino Acids and Cardiometabolic Disease. J Am Heart Assoc. 2024;13(7):e031617.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10820_CR47","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542\u201356.","journal-title":"J Hepatol"},{"key":"10820_CR48","doi-asserted-by":"crossref","unstructured":"Baratta F, Pastori D, Angelico F, Balla A, Paganini AM, Cocomello N et al. Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study. Clin Gastroenterol Hepatol. 2020;18(10):2324-31.e4.","DOI":"10.1016\/j.cgh.2019.12.026"},{"issue":"8","key":"10820_CR49","doi-asserted-by":"publisher","first-page":"e036663","DOI":"10.1136\/bmjopen-2019-036663","volume":"10","author":"X Ge","year":"2020","unstructured":"Ge X, Zheng L, Wang M, Du Y, Jiang J. Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990\u20132017: a population-based observational study. BMJ open. 2020;10(8):e036663.","journal-title":"BMJ open"},{"issue":"2","key":"10820_CR50","doi-asserted-by":"publisher","first-page":"e7809","DOI":"10.1590\/1414-431x20187809","volume":"52","author":"MVH Carvalho","year":"2019","unstructured":"Carvalho MVH, Kroll PC, Kroll RTM, Carvalho VN. Cirrhotic cardiomyopathy: the liver affects the heart. Brz J Me Biol Re. 2019;52(2):e7809.","journal-title":"Brz J Me Biol Re"},{"issue":"8","key":"10820_CR51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/jcdd12080295","volume":"12","author":"K Kostev","year":"2025","unstructured":"Kostev K, Sedighi J. Both Alcoholic and Non-Alcoholic Liver Cirrhosis Are Associated with an Increased Risk of HF-A Cohort Study Including 75,558 Patients. J Cardiovasc Dev Dis. 2025;12(8):295.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"11","key":"10820_CR52","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1161\/CIRCRESAHA.125.325492","volume":"136","author":"F Capone","year":"2025","unstructured":"Capone F, Vacca A. Decoding the Liver-Heart Axis in Cardiometabolic Diseases. Circ Res. 2025;136(11):1335\u201362.","journal-title":"Circ Res"},{"issue":"7","key":"10820_CR53","doi-asserted-by":"publisher","first-page":"101309","DOI":"10.1016\/j.jacbts.2025.05.004","volume":"10","author":"A Hakeem","year":"2025","unstructured":"Hakeem A, van Berlo J, Revelo XS. The Cardiohepatic Axis in Metabolic Disease: Liver to Heart. JACC Basic translational Sci. 2025;10(7):101309.","journal-title":"JACC Basic translational Sci"},{"issue":"2","key":"10820_CR54","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41574-018-0122-1","volume":"15","author":"DJ Stenvers","year":"2019","unstructured":"Stenvers DJ, Scheer F, Schrauwen P, la Fleur SE, Kalsbeek A. Circadian clocks and insulin resistance. Nat Rev Endocrinol. 2019;15(2):75\u201389.","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"10820_CR55","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41575-023-00792-1","volume":"20","author":"N Bolshette","year":"2023","unstructured":"Bolshette N, Ibrahim H, Reinke H, Asher G. Circadian regulation of liver function: from molecular mechanisms to disease pathophysiology. Nat Rev Gastroenterol Hepatol. 2023;20(11):695\u2013707.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10820_CR56","doi-asserted-by":"publisher","first-page":"1540267","DOI":"10.1155\/2016\/1540267","volume":"2016","author":"P Cheng","year":"2016","unstructured":"Cheng P, Zhang F, Yu L, Lin X, He L, Li X, Lu X, Yan X, Tan Y, Zhang C. Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases. J Diabetes Res. 2016;2016:1540267.","journal-title":"J Diabetes Res"},{"issue":"2","key":"10820_CR57","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/CIRCRESAHA.122.321369","volume":"132","author":"N El Jamal","year":"2023","unstructured":"El Jamal N, Lordan R. The Circadian Biology of Heart Failure. Circ Res. 2023;132(2):223\u201337.","journal-title":"Circ Res"},{"issue":"7271","key":"10820_CR58","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature08514","volume":"462","author":"R Lister","year":"2009","unstructured":"Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462(7271):315\u201322.","journal-title":"Nature"},{"issue":"11","key":"10820_CR59","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s12272-017-0973-3","volume":"40","author":"QA Abdul","year":"2017","unstructured":"Abdul QA, Yu BP, Chung HY, Jung HA, Choi JS. Epigenetic modifications of gene expression by lifestyle and environment. Arch Pharm Res. 2017;40(11):1219\u201337.","journal-title":"Arch Pharm Res"},{"key":"10820_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mad.2016.12.015","volume":"163","author":"A Sharma","year":"2017","unstructured":"Sharma A. Transgenerational epigenetics: Integrating soma to germline communication with gametic inheritance. Mech Ageing Dev. 2017;163:15\u201322.","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"10820_CR61","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cmet.2015.06.008","volume":"22","author":"AA Hardikar","year":"2015","unstructured":"Hardikar AA, Satoor SN, Karandikar MS, Joglekar MV, Puranik AS, Wong W, et al. Multigenerational Undernutrition Increases Susceptibility to Obesity and Diabetes that Is Not Reversed after Dietary Recuperation. Cell Metabol. 2015;22(2):312\u20139.","journal-title":"Cell Metabol"},{"issue":"1","key":"10820_CR62","doi-asserted-by":"publisher","first-page":"e55387","DOI":"10.1371\/journal.pone.0055387","volume":"8","author":"M Manikkam","year":"2013","unstructured":"Manikkam M, Tracey R, Guerrero-Bosagna C, Skinner MK. Plastics derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations. PLoS ONE. 2013;8(1):e55387.","journal-title":"PLoS ONE"},{"key":"10820_CR63","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.reprotox.2012.11.011","volume":"36","author":"R Tracey","year":"2013","unstructured":"Tracey R, Manikkam M, Guerrero-Bosagna C, Skinner MK. Hydrocarbons (jet fuel JP-8) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations. Reproductive Toxicol (Elmsford NY). 2013;36:104\u201316.","journal-title":"Reproductive Toxicol (Elmsford NY)"},{"issue":"2","key":"10820_CR64","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/shm\/7.2.229","volume":"7","author":"LH Lumey","year":"1994","unstructured":"Lumey LH, Van Poppel FW. The Dutch famine of 1944-45: mortality and morbidity in past and present generations. Soc Hist Med. 1994;7(2):229\u201346.","journal-title":"Soc Hist Med"},{"issue":"2","key":"10820_CR65","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/ajcn\/84.2.322","volume":"84","author":"RC Painter","year":"2006","unstructured":"Painter RC, de Rooij SR, Bossuyt PM, Simmers TA, Osmond C, Barker DJ, et al. Early onset of coronary artery disease after prenatal exposure to the Dutch famine. Am J Clin Nutr. 2006;84(2):322\u20137. quiz 466-7.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10820_CR66","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3945\/ajcn.2008.27038","volume":"89","author":"LH Lumey","year":"2009","unstructured":"Lumey LH, Stein AD, Kahn HS, Romijn JA. Lipid profiles in middle-aged men and women after famine exposure during gestation: the Dutch Hunger Winter Families Study. Am J Clin Nutr. 2009;89(6):1737\u201343.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10820_CR67","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/ajcn\/70.5.811","volume":"70","author":"AC Ravelli","year":"1999","unstructured":"Ravelli AC, van Der Meulen JH, Osmond C, Barker DJ, Bleker OP. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am J Clin Nutr. 1999;70(5):811\u20136.","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"10820_CR68","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/j.1471-0528.2008.01822.x","volume":"115","author":"RC Painter","year":"2008","unstructured":"Painter RC, Osmond C, Gluckman P, Hanson M, Phillips DI, Roseboom TJ. Transgenerational effects of prenatal exposure to the Dutch famine on neonatal adiposity and health in later life. BJOG. 2008;115(10):1243\u20139.","journal-title":"BJOG"},{"issue":"44","key":"10820_CR69","doi-asserted-by":"publisher","first-page":"17046","DOI":"10.1073\/pnas.0806560105","volume":"105","author":"BT Heijmans","year":"2008","unstructured":"Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA. 2008;105(44):17046\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10820_CR70","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1093\/hmg\/ddp353","volume":"18","author":"EW Tobi","year":"2009","unstructured":"Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet. 2009;18(21):4046\u201353.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10820_CR71","doi-asserted-by":"publisher","first-page":"e011768","DOI":"10.1136\/bmjopen-2016-011768","volume":"6","author":"S Finer","year":"2016","unstructured":"Finer S, Iqbal MS, Lowe R, Ogunkolade BW, Pervin S, Mathews C, et al. Is famine exposure during developmental life in rural Bangladesh associated with a metabolic and epigenetic signature in young adulthood? A historical cohort study. BMJ open. 2016;6(11):e011768.","journal-title":"BMJ open"},{"issue":"5","key":"10820_CR72","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/15592294.2019.1595297","volume":"14","author":"M Samblas","year":"2019","unstructured":"Samblas M, Milagro FI. DNA methylation markers in obesity, metabolic syndrome, and weight loss. Epigenetics. 2019;14(5):421\u201344.","journal-title":"Epigenetics"},{"key":"10820_CR73","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12881-014-0108-3","volume":"15","author":"D Chen","year":"2014","unstructured":"Chen D, Zhang A, Fang M, Fang R, Ge J, Jiang Y, et al. Increased methylation at differentially methylated region of GNAS in infants born to gestational diabetes. BMC Med Genet. 2014;15:108.","journal-title":"BMC Med Genet"},{"issue":"7635","key":"10820_CR74","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nature20784","volume":"541","author":"S Wahl","year":"2017","unstructured":"Wahl S, Drong A, Lehne B, Loh M, Scott WR, Kunze S, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017;541(7635):81\u20136.","journal-title":"Nature"},{"issue":"13","key":"10820_CR75","first-page":"3792","volume":"24","author":"T R\u00f6nn","year":"2015","unstructured":"R\u00f6nn T, Volkov P, Gillberg L, Kokosar M, Perfilyev A, Jacobsen AL, et al. Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood. Hum Mol Genet. 2015;24(13):3792\u2013813.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10820_CR76","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1373\/clinchem.2017.277921","volume":"64","author":"D Castellano-Castillo","year":"2018","unstructured":"Castellano-Castillo D, Moreno-Indias I, Fern\u00e1ndez-Garc\u00eda JC, Alcaide-Torres J, Moreno-Santos I, Oca\u00f1a L, et al. Adipose Tissue LPL Methylation is Associated with Triglyceride Concentrations in the Metabolic Syndrome. Clin Chem. 2018;64(1):210\u20138.","journal-title":"Clin Chem"},{"key":"10820_CR77","doi-asserted-by":"crossref","unstructured":"Westerman K, Sebastiani P, Jacques P, Liu S, DeMeo D, Ordov\u00e1s JM. DNA methylation modules associate with incident cardiovascular disease and cumulative risk factor exposure. 2019;11(1):142.","DOI":"10.1186\/s13148-019-0705-2"},{"key":"10820_CR78","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nature24277","volume":"550","author":"A Battle","year":"2017","unstructured":"Battle A, Brown C, Engelhardt B, Montgomery S. Genetic effects on gene expression across human tissues. Nature. 2017;550:204\u201313.","journal-title":"Nature"},{"issue":"11","key":"10820_CR79","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jamacardio.2021.2704","volume":"6","author":"A Navas-Acien","year":"2021","unstructured":"Navas-Acien A, Domingo-Relloso A, Subedi P, Riffo-Campos AL, Xia R, Gomez L, et al. Blood DNA Methylation and Incident Coronary Heart Disease: Evidence From the Strong Heart Study. JAMA Cardiol. 2021;6(11):1237\u201346.","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10820_CR80","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1161\/ATVBAHA.113.301765","volume":"33","author":"A Kumar","year":"2013","unstructured":"Kumar A, Kumar S, Vikram A, Hoffman TA, Naqvi A, Lewarchik CM, et al. Histone and DNA methylation-mediated epigenetic downregulation of endothelial Kruppel-like factor 2 by low-density lipoprotein cholesterol. Arterioscler Thromb Vasc Biol. 2013;33(8):1936\u201342.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10820_CR81","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s10753-017-0599-0","volume":"40","author":"Z Yan","year":"2017","unstructured":"Yan Z, Deng Y, Jiao F, Guo J, Ou H. Lipopolysaccharide Downregulates Kruppel-Like Factor 2 (KLF2) via Inducing DNMT1-Mediated Hypermethylation in Endothelial Cells. Inflammation. 2017;40(5):1589\u201398.","journal-title":"Inflammation"},{"issue":"16","key":"10820_CR82","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.119.044444","volume":"142","author":"A Madsen","year":"2020","unstructured":"Madsen A, H\u00f6ppner G, Krause J, Hirt MN, Laufer SD, Schweizer M, et al. An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility. Circulation. 2020;142(16):1562\u201378.","journal-title":"Circulation"},{"issue":"3","key":"10820_CR83","doi-asserted-by":"publisher","first-page":"e005765","DOI":"10.1161\/CIRCHEARTFAILURE.118.005765","volume":"12","author":"N Glezeva","year":"2019","unstructured":"Glezeva N, Moran B, Collier P, Moravec CS, Phelan D, Donnellan E, et al. Targeted DNA Methylation Profiling of Human Cardiac Tissue Reveals Novel Epigenetic Traits and Gene Deregulation Across Different Heart Failure Patient Subtypes. Circulation Heart Fail. 2019;12(3):e005765.","journal-title":"Circulation Heart Fail"},{"issue":"10","key":"10820_CR84","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1161\/CIRCRESAHA.121.320251","volume":"130","author":"XLS Dai","year":"2022","unstructured":"Dai XLS, Cheng L, Huang T, Guo H, Wang D, Xia M, Ling W, Xiao Y. Epigenetic Upregulation of H19 and AMPK Inhibition Concurrently Contribute to S-Adenosylhomocysteine Hydrolase Deficiency-Promoted Atherosclerotic Calcification. Circul Res. 2022;130(10):1565\u201382.","journal-title":"Circul Res"},{"issue":"4","key":"10820_CR85","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/HYPERTENSIONAHA.121.18584","volume":"79","author":"ML Roberts","year":"2022","unstructured":"Roberts ML, Kotchen TA, Pan X, Li Y. Unique Associations of DNA Methylation Regions With 24-Hour Blood Pressure Phenotypes in Black Participants. Hypertension. 2022;79(4):761\u201372.","journal-title":"Hypertension"},{"issue":"5","key":"10820_CR86","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1097\/HJH.0000000000003103","volume":"40","author":"SED Putra","year":"2022","unstructured":"Putra SED, Reichetzeder C, von Websky K, Neuber C, Halle H, Kleuser B, et al. Association between placental global DNA methylation and blood pressure during human pregnancy. J Hypertens. 2022;40(5):1002\u20139.","journal-title":"J Hypertens"},{"issue":"8","key":"10820_CR87","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41440-018-0057-x","volume":"41","author":"F Jin","year":"2018","unstructured":"Jin F, Li X, Wang Z, Liu Y, Liu J, Sun D, et al. Association of mitofusin 2 methylation and essential hypertension: a case-control study in a Chinese population. Hypertens research: official J Japanese Soc Hypertens. 2018;41(8):605\u201313.","journal-title":"Hypertens research: official J Japanese Soc Hypertens"},{"issue":"4","key":"10820_CR88","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1620\/tjem.244.283","volume":"244","author":"XJ Bao","year":"2018","unstructured":"Bao XJ, Mao SQ, Gu TL, Zheng SY, Zhao JS, Zhang LN. Hypomethylation of the Interferon \u03b3 Gene as a Potential Risk Factor for Essential Hypertension: A Case-Control Study. Tohoku J Exp Med. 2018;244(4):283\u201390.","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"10820_CR89","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2004.11.004","volume":"180","author":"HS Lim","year":"2005","unstructured":"Lim HS, Lip GY, Blann AD. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage\/dysfunction and atherosclerosis. Atherosclerosis. 2005;180(1):113\u20138.","journal-title":"Atherosclerosis"},{"issue":"1","key":"10820_CR90","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12872-022-02882-5","volume":"22","author":"Y Chen","year":"2022","unstructured":"Chen Y, Xu X, Chen Z, Huang B, Wang X, Fan X. DNA methylation alternation in Stanford- A acute aortic dissection. BMC Cardiovasc Disord. 2022;22(1):455.","journal-title":"BMC Cardiovasc Disord"},{"issue":"9","key":"10820_CR91","doi-asserted-by":"publisher","first-page":"e0183488","DOI":"10.1371\/journal.pone.0183488","volume":"12","author":"K Pfuhlmann","year":"2017","unstructured":"Pfuhlmann K, Pfluger PT, Schriever SC, M\u00fcller TD, Tsch\u00f6p MH, Stemmer K. Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice. PLoS ONE. 2017;12(9):e0183488.","journal-title":"PLoS ONE"},{"issue":"7","key":"10820_CR92","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1101\/gad.1284005","volume":"19","author":"M Tachibana","year":"2005","unstructured":"Tachibana M, Ueda J, Fukuda M, Takeda N, Ohta T, Iwanari H, et al. Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9. Genes Dev. 2005;19(7):815\u201326.","journal-title":"Genes Dev"},{"key":"10820_CR93","doi-asserted-by":"crossref","unstructured":"Mattagajasingh I, Kim C-S, Naqvi A, Yamamori T, Hoffman TA, Jung S-B et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proceedings of the National Academy of Sciences. 2007;104(37):14855-60.","DOI":"10.1073\/pnas.0704329104"},{"issue":"7","key":"10820_CR94","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/CIRCRESAHA.110.222968","volume":"107","author":"SB Jung","year":"2010","unstructured":"Jung SB, Kim CS, Naqvi A, Yamamori T, Mattagajasingh I, Hoffman TA, et al. Histone deacetylase 3 antagonizes aspirin-stimulated endothelial nitric oxide production by reversing aspirin-induced lysine acetylation of endothelial nitric oxide synthase. Circul Res. 2010;107(7):877\u201387.","journal-title":"Circul Res"},{"key":"10820_CR95","doi-asserted-by":"publisher","first-page":"9494052","DOI":"10.1155\/2018\/9494052","volume":"2018","author":"Y Leng","year":"2018","unstructured":"Leng Y, Wu Y, Lei S. Inhibition of HDAC6 Activity Alleviates Myocardial Ischemia\/Reperfusion Injury in Diabetic Rats: Potential Role of Peroxiredoxin 1 Acetylation and Redox Regulation. Oxid Med Cell Longev. 2018;2018:9494052.","journal-title":"Oxid Med Cell Longev"},{"issue":"351","key":"10820_CR96","doi-asserted-by":"publisher","first-page":"ra106","DOI":"10.1126\/scisignal.2005375","volume":"7","author":"S Shinozaki","year":"2014","unstructured":"Shinozaki S, Chang K, Sakai M, Shimizu N, Yamada M, Tanaka T, et al. Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65. Sci Signal. 2014;7(351):ra106.","journal-title":"Sci Signal"},{"key":"10820_CR97","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12933-015-0299-8","volume":"14","author":"M Ding","year":"2015","unstructured":"Ding M, Lei J, Han H, Li W, Qu Y, Fu E, et al. SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats. Cardiovasc Diabetol. 2015;14:143.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10820_CR98","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1159\/000490216","volume":"47","author":"Y Lu","year":"2018","unstructured":"Lu Y, Feng Y, Liu D, Zhang Z, Gao K, Zhang W, et al. Thymoquinone Attenuates Myocardial Ischemia\/Reperfusion Injury Through Activation of SIRT1 Signaling. Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol. 2018;47(3):1193\u2013206.","journal-title":"Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol"},{"issue":"4","key":"10820_CR99","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10495-016-1341-3","volume":"22","author":"Y Wang","year":"2017","unstructured":"Wang Y, Mu Y, Zhou X, Ji H, Gao X, Cai WW, et al. SIRT2-mediated FOXO3a deacetylation drives its nuclear translocation triggering FasL-induced cell apoptosis during renal ischemia reperfusion. Apoptosis: Int J Program cell death. 2017;22(4):519\u201330.","journal-title":"Apoptosis: Int J Program cell death"},{"key":"10820_CR100","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.yjmcc.2015.03.017","volume":"84","author":"T Bochaton","year":"2015","unstructured":"Bochaton T, Crola-Da-Silva C, Pillot B, Villedieu C, Ferreras L, Alam MR, et al. Inhibition of myocardial reperfusion injury by ischemic postconditioning requires sirtuin 3-mediated deacetylation of cyclophilin D. J Mol Cell Cardiol. 2015;84:61\u20139.","journal-title":"J Mol Cell Cardiol"},{"issue":"21","key":"10820_CR101","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.117.028728","volume":"136","author":"X Tang","year":"2017","unstructured":"Tang X, Chen XF, Wang NY, Wang XM, Liang ST, Zheng W, et al. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy. Circulation. 2017;136(21):2051\u201367.","journal-title":"Circulation"},{"issue":"18","key":"10820_CR102","first-page":"1389","volume":"38","author":"YX Luo","year":"2017","unstructured":"Luo YX, Tang X, An XZ, Xie XM, Chen XF, Zhao X, et al. SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity. Eur Heart J. 2017;38(18):1389\u201398.","journal-title":"Eur Heart J"},{"issue":"5","key":"10820_CR103","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1128\/MCB.00586-15","volume":"36","author":"NR Sundaresan","year":"2015","unstructured":"Sundaresan NR, Bindu S, Pillai VB, Samant S, Pan Y, Huang JY, et al. SIRT3 Blocks Aging-Associated Tissue Fibrosis in Mice by Deacetylating and Activating Glycogen Synthase Kinase 3\u03b2. Mol Cell Biol. 2015;36(5):678\u201392.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10820_CR104","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jphs.2016.03.013","volume":"132","author":"P Shen","year":"2016","unstructured":"Shen P, Feng X, Zhang X, Huang X, Liu S, Lu X, et al. SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300. J Pharmacol Sci. 2016;132(1):31\u201340.","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"10820_CR105","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cvr\/cvx228","volume":"114","author":"C Collesi","year":"2018","unstructured":"Collesi C, Felician G, Secco I, Gutierrez MI, Martelletti E, Ali H, et al. Reversible Notch1 acetylation tunes proliferative signalling in cardiomyocytes. Cardiovascular Res. 2018;114(1):103\u201322.","journal-title":"Cardiovascular Res"},{"issue":"10","key":"10820_CR106","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1161\/01.RES.0000147557.75257.ff","volume":"95","author":"RR Alcendor","year":"2004","unstructured":"Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, Sadoshima J. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circul Res. 2004;95(10):971\u201380.","journal-title":"Circul Res"},{"issue":"7","key":"10820_CR107","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.15252\/embr.201643686","volume":"18","author":"A Abend","year":"2017","unstructured":"Abend A, Shkedi O, Fertouk M, Caspi LH, Kehat I. Salt-inducible kinase induces cytoplasmic histone deacetylase 4 to promote vascular calcification. EMBO Rep. 2017;18(7):1166\u201385.","journal-title":"EMBO Rep"},{"key":"10820_CR108","doi-asserted-by":"publisher","first-page":"104281","DOI":"10.1016\/j.phrs.2019.104281","volume":"146","author":"Z Chi","year":"2019","unstructured":"Chi Z, Byeon HE, Seo E, Nguyen QT, Lee W, Jeong Y, et al. Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine \u03b3-lyase protein degradation. Pharmacol Res. 2019;146:104281.","journal-title":"Pharmacol Res"},{"issue":"7779","key":"10820_CR109","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"key":"10820_CR110","doi-asserted-by":"publisher","first-page":"949252","DOI":"10.3389\/fgene.2022.949252","volume":"13","author":"Y Xie","year":"2022","unstructured":"Xie Y, Hu H, Liu M, Zhou T, Cheng X, Huang W, et al. The role and mechanism of histone lactylation in health and diseases. Front Genet. 2022;13:949252.","journal-title":"Front Genet"},{"issue":"6765","key":"10820_CR111","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/47412","volume":"403","author":"BD Strahl","year":"2000","unstructured":"Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000;403(6765):41\u20135.","journal-title":"Nature"},{"issue":"2","key":"10820_CR112","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.devcel.2020.06.036","volume":"54","author":"G Figlia","year":"2020","unstructured":"Figlia G, Willnow P, Teleman AA. Metabolites regulate cell signaling and growth via covalent modification of proteins. Dev Cell. 2020;54(2):156\u201370.","journal-title":"Dev Cell"},{"issue":"3","key":"10820_CR113","doi-asserted-by":"publisher","first-page":"eabi6696","DOI":"10.1126\/sciadv.abi6696","volume":"8","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela C, Zhang D, Wei W, B\u00e6k M, Liu W, Gao J, et al. Class I histone deacetylases (HDAC1\u20133) are histone lysine delactylases. Sci Adv. 2022;8(3):eabi6696.","journal-title":"Sci Adv"},{"issue":"1","key":"10820_CR114","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41422-023-00864-6","volume":"34","author":"Y Mao","year":"2024","unstructured":"Mao Y, Zhang J, Zhou Q, He X, Zheng Z, Wei Y, et al. Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylation. Cell Res. 2024;34(1):13\u201330.","journal-title":"Cell Res"},{"issue":"6","key":"10820_CR115","doi-asserted-by":"publisher","first-page":"167247","DOI":"10.1016\/j.bbadis.2024.167247","volume":"1870","author":"J Lin","year":"2024","unstructured":"Lin J, Ren J. Lactate-induced lactylation and cardiometabolic diseases: From epigenetic regulation to therapeutics. Biochim et Biophys Acta (BBA) - Mol Basis Disease. 2024;1870(6):167247.","journal-title":"Biochim et Biophys Acta (BBA) - Mol Basis Disease"},{"key":"10820_CR116","doi-asserted-by":"publisher","first-page":"101454","DOI":"10.1016\/j.redox.2020.101454","volume":"35","author":"GA Brooks","year":"2020","unstructured":"Brooks GA. Lactate as a fulcrum of metabolism. Redox Biol. 2020;35:101454.","journal-title":"Redox Biol"},{"issue":"23","key":"10820_CR117","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1113\/jphysiol.2009.178350","volume":"587","author":"GA Brooks","year":"2009","unstructured":"Brooks GA. Cell\u2013cell and intracellular lactate shuttles. J Physiol. 2009;587(23):5591\u2013600.","journal-title":"J Physiol"},{"issue":"7779","key":"10820_CR118","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"key":"10820_CR119","doi-asserted-by":"publisher","first-page":"688910","DOI":"10.3389\/fimmu.2021.688910","volume":"12","author":"A-N Chen","year":"2021","unstructured":"Chen A-N, Luo Y, Yang Y-H, Fu J-T, Geng X-M, Shi J-P, et al. Lactylation, a novel metabolic reprogramming code: current status and prospects. Front Immunol. 2021;12:688910.","journal-title":"Front Immunol"},{"issue":"2","key":"10820_CR120","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41422-023-00872-6","volume":"34","author":"H Ren","year":"2024","unstructured":"Ren H, Zhang D. Lactylation constrains OXPHOS under hypoxia. Cell Res. 2024;34(2):91\u20132.","journal-title":"Cell Res"},{"key":"10820_CR121","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tig.2021.09.009","volume":"38","author":"X Dai","year":"2022","unstructured":"Dai X, Lv X, Thompson EW, Ostrikov KK. Histone lactylation: epigenetic mark of glycolytic switch. Trends Genet. 2022;38:124\u20137.","journal-title":"Trends Genet"},{"issue":"1","key":"10820_CR122","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12933-024-02178-2","volume":"23","author":"XM Ma","year":"2024","unstructured":"Ma XM, Geng K, Wang P, Jiang Z, Law BY-K, Xu Y. MCT4-dependent lactate transport: a novel mechanism for cardiac energy metabolism injury and inflammation in type 2 diabetes mellitus. Cardiovasc Diabetol. 2024;23(1):96.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10820_CR123","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s44321-024-00025-1","volume":"16","author":"X Chen","year":"2024","unstructured":"Chen X, Wang Y, Wang J-N, Zhang Y-C, Zhang Y-R, Sun R-X, et al. Lactylation-driven FTO targets CDK2 to aggravate microvascular anomalies in diabetic retinopathy. EMBO Mol Med. 2024;16(2):294.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10820_CR124","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jdiacomp.2015.08.022","volume":"30","author":"Y Cao","year":"2016","unstructured":"Cao Y, Jiang X, Ma H, Wang Y, Xue P, Liu Y. SIRT1 and insulin resistance. J Diabetes Complicat. 2016;30(1):178\u201383.","journal-title":"J Diabetes Complicat"},{"issue":"1","key":"10820_CR125","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s11357-023-00863-w","volume":"46","author":"A Yu","year":"2024","unstructured":"Yu A, Yu R, Liu H, Ge C, Dang W. SIRT1 safeguards adipogenic differentiation by orchestrating anti-oxidative responses and suppressing cellular senescence. Geroscience. 2024;46(1):1107\u201327.","journal-title":"Geroscience"},{"issue":"3","key":"10820_CR126","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.cell.2012.06.027","volume":"150","author":"L Qiang","year":"2012","unstructured":"Qiang L, Wang L, Kon N, Zhao W, Lee S, Zhang Y, et al. Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Ppar\u03b3. Cell. 2012;150(3):620\u201332.","journal-title":"Cell"},{"key":"10820_CR127","doi-asserted-by":"publisher","first-page":"122187","DOI":"10.1016\/j.lfs.2023.122187","volume":"333","author":"J Chen","year":"2023","unstructured":"Chen J, Wang Q, Li R, Li Z, Jiang Q, Yan F, et al. The role of sirtuins in the regulatin of oxidative stress during the progress and therapy of type 2 diabetes mellitus. Life Sci. 2023;333:122187.","journal-title":"Life Sci"},{"issue":"10","key":"10820_CR128","doi-asserted-by":"publisher","first-page":"110911","DOI":"10.1016\/j.isci.2024.110911","volume":"27","author":"R Du","year":"2024","unstructured":"Du R, Gao Y, Yan C, Ren X, Qi S, Liu G, et al. Sirtuin 1\/sirtuin 3 are robust lysine delactylases and sirtuin 1-mediated delactylation regulates glycolysis. iScience. 2024;27(10):110911.","journal-title":"iScience"},{"key":"10820_CR129","doi-asserted-by":"publisher","first-page":"1489438","DOI":"10.3389\/fcvm.2024.1489438","volume":"11","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhao J, Yu J, Zhang X, Ran S, Wang S, et al. Lactate metabolism and lactylation in cardiovascular disease: novel mechanisms and therapeutic targets. Front Cardiovasc Med. 2024;11:1489438.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"10820_CR130","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41422-023-00844-w","volume":"33","author":"N Zhang","year":"2023","unstructured":"Zhang N, Zhang Y, Xu J, Wang P, Wu B, Lu S, et al. \u03b1-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure. Cell Res. 2023;33(9):679\u201398.","journal-title":"Cell Res"},{"key":"10820_CR131","doi-asserted-by":"publisher","first-page":"715081","DOI":"10.3389\/fphys.2021.715081","volume":"12","author":"S Dong","year":"2021","unstructured":"Dong S, Qian L, Cheng Z, Chen C, Wang K, Hu S, et al. Lactate and Myocardiac Energy Metabolism. Front Physiol. 2021;12:715081.","journal-title":"Front Physiol"},{"issue":"3","key":"10820_CR132","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41569-021-00513-8","volume":"18","author":"I Fernandez-Ruiz","year":"2021","unstructured":"Fernandez-Ruiz I. Rebalancing the pyruvate\u2013lactate axis to treat heart failure. Nat Rev Cardiol. 2021;18(3):150\u20131.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10820_CR133","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmet.2020.12.003","volume":"33","author":"AA Cluntun","year":"2021","unstructured":"Cluntun AA, Badolia R, Lettlova S, Parnell KM, Shankar TS, Diakos NA, et al. The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metabol. 2021;33(3):629\u2013e4810.","journal-title":"Cell Metabol"},{"issue":"1","key":"10820_CR134","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nchembio.495","volume":"7","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Tan M, Xie Z, Dai L, Chen Y, Zhao Y. Identification of lysine succinylation as a new post-translational modification. Nat Chem Biol. 2011;7(1):58\u201363.","journal-title":"Nat Chem Biol"},{"issue":"16","key":"10820_CR135","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1073\/pnas.1519858113","volume":"113","author":"S Sadhukhan","year":"2016","unstructured":"Sadhukhan S, Liu X, Ryu D, Nelson OD, Stupinski JA, Li Z, et al. Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function. Proc Natl Acad Sci U S A. 2016;113(16):4320\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10820_CR136","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.gendis.2019.09.011","volume":"7","author":"A Sreedhar","year":"2020","unstructured":"Sreedhar A, Wiese EK, Hitosugi T. Enzymatic and metabolic regulation of lysine succinylation. Genes Dis. 2020;7(2):166\u201371.","journal-title":"Genes Dis"},{"issue":"4","key":"10820_CR137","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.gendis.2022.03.009","volume":"10","author":"G Zhao","year":"2023","unstructured":"Zhao G, Zhen J, Liu X, Guo J, Li D, Xie J, et al. Protein post-translational modification by lysine succinylation: Biochemistry, biological implications, and therapeutic opportunities. Genes Dis. 2023;10(4):1242\u201362.","journal-title":"Genes Dis"},{"issue":"7684","key":"10820_CR138","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature25003","volume":"552","author":"Y Wang","year":"2017","unstructured":"Wang Y, Guo YR, Liu K, Yin Z, Liu R, Xia Y, et al. KAT2A coupled with the \u03b1-KGDH complex acts as a histone H3 succinyltransferase. Nature. 2017;552(7684):273\u20137.","journal-title":"Nature"},{"issue":"1","key":"10820_CR139","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/jcmm.13920","volume":"23","author":"C Wang","year":"2019","unstructured":"Wang C, Zhang C, Li X, Shen J, Xu Y, Shi H, et al. CPT1A-mediated succinylation of S100A10 increases human gastric cancer invasion. J Cell Mol Med. 2019;23(1):293\u2013305.","journal-title":"J Cell Mol Med"},{"key":"10820_CR140","doi-asserted-by":"publisher","first-page":"103932","DOI":"10.1016\/j.redox.2025.103932","volume":"88","author":"F Mu","year":"2025","unstructured":"Mu F, Zhang H, Gong R, Lin R, Zhao M, Tao X, et al. Lysine succinylation as a metabolic switch in cardiovascular diseases: Mechanistic insights and therapeutic perspectives. Redox Biol. 2025;88:103932.","journal-title":"Redox Biol"},{"key":"10820_CR141","doi-asserted-by":"publisher","first-page":"114931","DOI":"10.1016\/j.biopha.2023.114931","volume":"164","author":"YP Liu","year":"2023","unstructured":"Liu YP, Wen R, Liu CF, Zhang TN, Yang N. Cellular and molecular biology of sirtuins in cardiovascular disease. Biomed Pharmacother. 2023;164:114931.","journal-title":"Biomed Pharmacother"},{"key":"10820_CR142","doi-asserted-by":"publisher","first-page":"103184","DOI":"10.1016\/j.redox.2024.103184","volume":"73","author":"M Wu","year":"2024","unstructured":"Wu M, Tan J, Cao Z, Cai Y, Huang Z, Chen Z, et al. Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation. Redox Biol. 2024;73:103184.","journal-title":"Redox Biol"},{"issue":"2","key":"10820_CR143","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11684-022-0943-0","volume":"17","author":"Y Xu","year":"2023","unstructured":"Xu Y, Ye X, Zhou Y, Cao X, Peng S, Peng Y, et al. Sodium butyrate activates HMGCS2 to promote ketone body production through SIRT5-mediated desuccinylation. Front Med. 2023;17(2):339\u201351.","journal-title":"Front Med"},{"issue":"1","key":"10820_CR144","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bbrc.2013.10.033","volume":"441","author":"ZF Lin","year":"2013","unstructured":"Lin ZF, Xu HB, Wang JY, Lin Q, Ruan Z, Liu FB, et al. SIRT5 desuccinylates and activates SOD1 to eliminate ROS. Biochem Biophys Res Commun. 2013;441(1):191\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10820_CR145","doi-asserted-by":"publisher","first-page":"811","DOI":"10.15252\/embr.201541643","volume":"17","author":"L Zhou","year":"2016","unstructured":"Zhou L, Wang F, Sun R, Chen X, Zhang M, Xu Q, et al. SIRT5 promotes IDH2 desuccinylation and G6PD deglutarylation to enhance cellular antioxidant defense. EMBO Rep. 2016;17(6):811\u201322.","journal-title":"EMBO Rep"},{"issue":"5","key":"10820_CR146","doi-asserted-by":"publisher","first-page":"e45124","DOI":"10.15252\/embr.201745124","volume":"19","author":"XF Chen","year":"2018","unstructured":"Chen XF, Tian MX. SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer. EMBO Rep. 2018;19(5):e45124.","journal-title":"EMBO Rep"},{"key":"10820_CR147","doi-asserted-by":"publisher","first-page":"687559","DOI":"10.3389\/fcell.2021.687559","volume":"9","author":"B Zhou","year":"2021","unstructured":"Zhou B, Xiao M, Hu H, Pei X, Xue Y, Miao G, et al. Cardioprotective Role of SIRT5 in Response to Acute Ischemia Through a Novel Liver-Cardiac Crosstalk Mechanism. Front cell Dev biology. 2021;9:687559.","journal-title":"Front cell Dev biology"},{"issue":"1","key":"10820_CR148","doi-asserted-by":"publisher","first-page":"2271196","DOI":"10.1080\/10641963.2023.2271196","volume":"45","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhou H, Wu J, Ye S. MG53 alleviates hypoxia\/reoxygenation-induced cardiomyocyte injury by succinylation and ubiquitination modification. Clin Exp Hypertens. 2023;45(1):2271196.","journal-title":"Clin Exp Hypertens"},{"issue":"1","key":"10820_CR149","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13578-021-00629-x","volume":"11","author":"W Zhong","year":"2021","unstructured":"Zhong W, Benissan-Messan DZ, Ma J, Cai C, Lee PHU. Cardiac effects and clinical applications of MG53. Cell Biosci. 2021;11(1):115.","journal-title":"Cell Biosci"},{"issue":"6","key":"10820_CR150","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2011.08.008","volume":"146","author":"M Tan","year":"2011","unstructured":"Tan M, Luo H, Lee S, Jin F, Yang JS, Montellier E, et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell. 2011;146(6):1016\u201328.","journal-title":"Cell"},{"issue":"4","key":"10820_CR151","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.stem.2020.12.009","volume":"28","author":"Y Fang","year":"2021","unstructured":"Fang Y, Xu X, Ding J, Yang L, Doan MT, Karmaus PWF, et al. Histone crotonylation promotes mesoendodermal commitment of human embryonic stem cells. Cell Stem Cell. 2021;28(4):748\u2013. \u2013\u200963.e7.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"10820_CR152","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/cr.2017.60","volume":"27","author":"W Xu","year":"2017","unstructured":"Xu W, Wan J, Zhan J, Li X, He H, Shi Z, et al. Global profiling of crotonylation on non-histone proteins. Cell Res. 2017;27(7):946\u20139.","journal-title":"Cell Res"},{"key":"10820_CR153","doi-asserted-by":"crossref","unstructured":"Wei W, Mao A, Tang B, Zeng Q, Gao S, Liu X et al. Large-Scale Identification of Protein Crotonylation Reveals Its Role in Multiple Cellular Functions. 2017;16(4):1743\u201352.","DOI":"10.1021\/acs.jproteome.7b00012"},{"key":"10820_CR154","doi-asserted-by":"crossref","unstructured":"Yang P, Qin Y, Zeng L, He Y, Xie Y, Cheng X, et al. Crotonylation and disease: Current progress and future perspectives. Volume 165. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie; 2023. p. 115108.","DOI":"10.1016\/j.biopha.2023.115108"},{"issue":"10","key":"10820_CR155","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1161\/CIRCULATIONAHA.120.049438","volume":"143","author":"X Tang","year":"2021","unstructured":"Tang X, Chen XF, Sun X, Xu P, Zhao X, Tong Y, et al. Short-Chain Enoyl-CoA Hydratase Mediates Histone Crotonylation and Contributes to Cardiac Homeostasis. Circulation. 2021;143(10):1066\u20139.","journal-title":"Circulation"},{"issue":"2","key":"10820_CR156","doi-asserted-by":"publisher","first-page":"45696","DOI":"10.31083\/RCM45696","volume":"27","author":"X Hu","year":"2026","unstructured":"Hu X, Zhang Y, Zhao Q, Li Y, Wu X, Lactylation. Crotonylation and Succinylation: Decoding Their Roles in the Progression of Cardiovascular Disease. Rev Cardiovasc Med. 2026;27(2):45696.","journal-title":"Rev Cardiovasc Med"},{"issue":"7","key":"10820_CR157","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat reviews Cardiol. 2018;15(7):387\u2013407.","journal-title":"Nat reviews Cardiol"},{"issue":"9","key":"10820_CR158","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1161\/CIRCRESAHA.118.313865","volume":"124","author":"PA Gorski","year":"2019","unstructured":"Gorski PA, Jang SP, Jeong D, Lee A, Lee P, Oh JG, et al. Role of SIRT1 in Modulating Acetylation of the Sarco-Endoplasmic Reticulum Ca(2+)-ATPase in Heart Failure. Circul Res. 2019;124(9):e63\u201380.","journal-title":"Circul Res"},{"issue":"5","key":"10820_CR159","doi-asserted-by":"publisher","first-page":"e100020","DOI":"10.15252\/embj.2018100020","volume":"38","author":"A Sitsel","year":"2019","unstructured":"Sitsel A, De Raeymaecker J, Drachmann ND, Derua R, Smaardijk S, Andersen JL, et al. Structures of the heart specific SERCA2a Ca(2+)-ATPase. EMBO J. 2019;38(5):e100020.","journal-title":"EMBO J"},{"issue":"12","key":"10820_CR160","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","volume":"18","author":"D Montaigne","year":"2021","unstructured":"Montaigne D, Butruille L, Staels B. PPAR control of metabolism and cardiovascular functions. Nat Rev Cardiol. 2021;18(12):809\u201323.","journal-title":"Nat Rev Cardiol"},{"key":"10820_CR161","doi-asserted-by":"publisher","first-page":"125151","DOI":"10.1016\/j.ijbiomac.2023.125151","volume":"242","author":"H-X Chen","year":"2023","unstructured":"Chen H-X, Wang X-C, Hou H-T, Wang J, Yang Q, Chen Y-L, et al. Lysine crotonylation of SERCA2a correlates to cardiac dysfunction and arrhythmia in Sirt1 cardiac-specific knockout mice. Int J Biol Macromol. 2023;242:125151.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"10820_CR162","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/ATVBAHA.116.307923","volume":"37","author":"J Zhuang","year":"2017","unstructured":"Zhuang J, Luan P, Li H, Wang K, Zhang P, Xu Y, et al. The Yin\u2013Yang dynamics of DNA methylation is the key regulator for smooth muscle cell phenotype switch and vascular remodeling. Arterioscler Thromb Vasc Biol. 2017;37(1):84\u201397.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10820_CR163","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1210\/en.2014-1595","volume":"155","author":"Q Cao","year":"2014","unstructured":"Cao Q, Wang X, Jia L, Mondal AK, Diallo A, Hawkins GA, et al. Inhibiting DNA Methylation by 5-Aza-2\u2019-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology. 2014;155(12):4925\u201338.","journal-title":"Endocrinology"},{"issue":"1","key":"10820_CR164","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bbadis.2006.10.004","volume":"1772","author":"J Kim","year":"2007","unstructured":"Kim J, Kim JY, Song KS, Lee YH, Seo JS, Jelinek J, et al. Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim Biophys Acta. 2007;1772(1):72\u201380.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10820_CR165","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1074248415591698","volume":"21","author":"CJ Watson","year":"2016","unstructured":"Watson CJ, Horgan S, Neary R, Glezeva N, Tea I, Corrigan N, et al. Epigenetic therapy for the treatment of hypertension-induced cardiac hypertrophy and fibrosis. J Cardiovasc Pharmacol Therap. 2016;21(1):127\u201337.","journal-title":"J Cardiovasc Pharmacol Therap"},{"issue":"6","key":"10820_CR166","doi-asserted-by":"publisher","first-page":"C425","DOI":"10.1152\/ajpcell.00058.2015","volume":"309","author":"X Fang","year":"2015","unstructured":"Fang X, Robinson J, Wang-Hu J, Jiang L, Freeman DA, Rivkees SA, et al. cAMP induces hypertrophy and alters DNA methylation in HL-1 cardiomyocytes. Am J Physiol Cell Physiol. 2015;309(6):C425\u201336.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10820_CR167","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/biomedicines9020199","volume":"9","author":"U Tanaka","year":"2021","unstructured":"Tanaka U, Kajioka S, Finoti LS, Palioto DB. Decitabine Inhibits Bone Resorption in Periodontitis by Upregulating Anti-Inflammatory Cytokines and Suppressing Osteoclastogenesis. Biomedicines. 2021;9(2):199.","journal-title":"Biomedicines"},{"issue":"1","key":"10820_CR168","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/CCM.0b013e3181b4a854","volume":"38","author":"YH Kao","year":"2010","unstructured":"Kao YH, Chen YC, Cheng CC, Lee TI, Chen YJ, Chen SA. Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes. Crit Care Med. 2010;38(1):217\u201322.","journal-title":"Crit Care Med"},{"issue":"3","key":"10820_CR169","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/cvr\/cvt264","volume":"101","author":"D Xiao","year":"2014","unstructured":"Xiao D, Dasgupta C, Chen M, Zhang K, Buchholz J, Xu Z, et al. Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats. Cardiovascular Res. 2014;101(3):373\u201382.","journal-title":"Cardiovascular Res"},{"key":"10820_CR170","doi-asserted-by":"publisher","first-page":"30053","DOI":"10.1038\/srep30053","volume":"6","author":"J Yu","year":"2016","unstructured":"Yu J, Qiu Y, Yang J, Bian S, Chen G, Deng M, et al. DNMT1-PPAR\u03b3 pathway in macrophages regulates chronic inflammation and atherosclerosis development in mice. Sci Rep. 2016;6:30053.","journal-title":"Sci Rep"},{"key":"10820_CR171","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.yjmcc.2018.05.012","volume":"120","author":"J Stenzig","year":"2018","unstructured":"Stenzig J, Schneeberger Y, L\u00f6ser A, Peters BS, Schaefer A, Zhao R-R, et al. Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats. J Mol Cell Cardiol. 2018;120:53\u201363.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10820_CR172","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1868-7083-6-14","volume":"6","author":"S-P Guay","year":"2014","unstructured":"Guay S-P, L\u00e9gar\u00e9 C, Houde A-A, Mathieu P, Boss\u00e9 Y, Bouchard L. Acetylsalicylic acid, aging and coronary artery disease are associated with ABCA1 DNA methylation in men. Clin Epigenetics. 2014;6(1):14.","journal-title":"Clin Epigenetics"},{"issue":"6","key":"10820_CR173","doi-asserted-by":"publisher","first-page":"e65744","DOI":"10.1371\/journal.pone.0065744","volume":"8","author":"A Crescenti","year":"2013","unstructured":"Crescenti A, Sol\u00e0 R, Valls RM, Caimari A, Del Bas JM, Anguera A, et al. Cocoa Consumption Alters the Global DNA Methylation of Peripheral Leukocytes in Humans with Cardiovascular Disease Risk Factors: A Randomized Controlled Trial. PLoS ONE. 2013;8(6):e65744.","journal-title":"PLoS ONE"},{"key":"10820_CR174","doi-asserted-by":"publisher","first-page":"710053","DOI":"10.3389\/fcvm.2021.710053","volume":"8","author":"Y Yang","year":"2021","unstructured":"Yang Y, Luan Y, Yuan RX, Luan Y. Histone Methylation Related Therapeutic Challenge in Cardiovascular Diseases. Front Cardiovasc Med. 2021;8:710053.","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10820_CR175","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.1002\/jcp.26576","volume":"233","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zhang Q, Gui L, Cai Y, Deng X, Li C, et al. Let-7e inhibits TNF-\u03b1 expression by targeting the methyl transferase EZH2 in DENV2-infected THP-1 cells. J Cell Physiol. 2018;233(11):8605\u201316.","journal-title":"J Cell Physiol"},{"issue":"48","key":"10820_CR176","doi-asserted-by":"publisher","first-page":"78331","DOI":"10.18632\/oncotarget.13048","volume":"7","author":"WS Zhu","year":"2016","unstructured":"Zhu WS, Tang CM, Xiao Z, Zhu JN, Lin QX, Fu YH, et al. Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts. Oncotarget. 2016;7(48):78331\u201342.","journal-title":"Oncotarget"},{"key":"10820_CR177","doi-asserted-by":"publisher","first-page":"13685","DOI":"10.1038\/ncomms13685","volume":"7","author":"JC Lui","year":"2016","unstructured":"Lui JC, Garrison P, Nguyen Q, Ad M, Keembiyehetty C, Chen W, et al. EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy. Nat Commun. 2016;7:13685.","journal-title":"Nat Commun"},{"issue":"8","key":"10820_CR178","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1158\/0008-5472.CAN-18-2395","volume":"79","author":"S Huang","year":"2019","unstructured":"Huang S, Wang Z, Zhou J, Huang J, Zhou L, Luo J, et al. EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells. Cancer Res. 2019;79(8):2009\u201320.","journal-title":"Cancer Res"},{"issue":"5Supplement1","key":"10820_CR179","doi-asserted-by":"publisher","first-page":"A012","DOI":"10.1158\/1538-7445.BRAIN23-A012","volume":"84","author":"LH Faruck","year":"2024","unstructured":"Faruck LH, Day C, Bhattarai S, Langfald A, Hinchcliffe E, Robinson J. Abstract A012: EZH2 as a therapeutic target for glioma. Cancer Res. 2024;84(5Supplement1):A012\u2013A.","journal-title":"Cancer Res"},{"issue":"10","key":"10820_CR180","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nchembio.1331","volume":"9","author":"W Kim","year":"2013","unstructured":"Kim W, Bird GH, Neff T, Guo G, Kerenyi MA, Walensky LD, et al. Targeted disruption of the EZH2\u2013EED complex inhibits EZH2-dependent cancer. Nat Chem Biol. 2013;9(10):643\u201350.","journal-title":"Nat Chem Biol"},{"issue":"6","key":"10820_CR181","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1021\/cb400133j","volume":"8","author":"KD Konze","year":"2013","unstructured":"Konze KD, Ma A, Li F, Barsyte-Lovejoy D, Parton T, MacNevin CJ, et al. An orally bioavailable chemical probe of the lysine methyltransferases EZH2 and EZH1. ACS Chem Biol. 2013;8(6):1324\u201334.","journal-title":"ACS Chem Biol"},{"issue":"9","key":"10820_CR182","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1101\/gad.1524107","volume":"21","author":"J Tan","year":"2007","unstructured":"Tan J, Yang X, Zhuang L, Jiang X, Chen W, Lee PL, et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 2007;21(9):1050\u201363.","journal-title":"Genes Dev"},{"key":"10820_CR183","doi-asserted-by":"publisher","first-page":"102365","DOI":"10.1016\/j.scr.2021.102365","volume":"53","author":"Y Tang","year":"2021","unstructured":"Tang Y, Zhao L, Yu X, Zhang J, Qian L, Jin J, et al. Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming. Stem Cell Res. 2021;53:102365.","journal-title":"Stem Cell Res"},{"issue":"12","key":"10820_CR184","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1113\/EP088881","volume":"105","author":"Y Liu","year":"2020","unstructured":"Liu Y, Dai C, Lei Y, Wu W, Liu W. Inhibition of EZH2 attenuates coronary heart disease by interacting with microRNA-22 to regulate the TXNIP\/nuclear factor-\u03baB pathway. Exp Physiol. 2020;105(12):2038\u201350.","journal-title":"Exp Physiol"},{"issue":"1","key":"10820_CR185","first-page":"30","volume":"12","author":"X Wei","year":"2020","unstructured":"Wei X, Yi X, Zhu XH, Jiang DS. Histone methylation vascular biology. 2020;12(1):30.","journal-title":"Histone methylation vascular biology"},{"issue":"1","key":"10820_CR186","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41420-020-00400-0","volume":"7","author":"K Ishiguro","year":"2021","unstructured":"Ishiguro K, Kitajima H, Niinuma T, Maruyama R, Nishiyama N, Ohtani H, et al. Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis. Cell Death Discov. 2021;7(1):7.","journal-title":"Cell Death Discov"},{"issue":"1","key":"10820_CR187","doi-asserted-by":"publisher","first-page":"e0116782","DOI":"10.1371\/journal.pone.0116782","volume":"10","author":"JD Fan","year":"2015","unstructured":"Fan JD, Lei PJ, Zheng JY, Wang X, Li S, Liu H, et al. The selective activation of p53 target genes regulated by SMYD2 in BIX-01294 induced autophagy-related cell death. PLoS ONE. 2015;10(1):e0116782.","journal-title":"PLoS ONE"},{"issue":"5","key":"10820_CR188","doi-asserted-by":"publisher","first-page":"e313","DOI":"10.1038\/bcj.2015.37","volume":"5","author":"YS Lai","year":"2015","unstructured":"Lai YS, Chen JY, Tsai HJ, Chen TY, Hung WC. The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells. Blood cancer J. 2015;5(5):e313.","journal-title":"Blood cancer J"},{"issue":"10","key":"10820_CR189","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/jcbfm.2015.99","volume":"35","author":"S Schweizer","year":"2015","unstructured":"Schweizer S, Harms C, Lerch H, Flynn J, Hecht J, Yildirim F, et al. Inhibition of histone methyltransferases SUV39H1 and G9a leads to neuroprotection in an in vitro model of cerebral ischemia. J Cereb Blood Flow Metab. 2015;35(10):1640\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"10820_CR190","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/bph.14959","volume":"177","author":"Y Luo","year":"2020","unstructured":"Luo Y, Fan C, Yang M, Dong M, Bucala R, Pei Z, et al. CD74 knockout protects against LPS-induced myocardial contractile dysfunction through AMPK-Skp2-SUV39H1-mediated demethylation of BCLB. Br J Pharmacol. 2020;177(8):1881\u201397.","journal-title":"Br J Pharmacol"},{"key":"10820_CR191","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.biocel.2016.06.021","volume":"78","author":"SH Lin","year":"2016","unstructured":"Lin SH, Ho WT, Wang YT, Chuang CT, Chuang LY, Guh JY. Histone methyltransferase Suv39h1 attenuates high glucose-induced fibronectin and p21(WAF1) in mesangial cells. Int J Biochem Cell Biol. 2016;78:96\u2013105.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"10820_CR192","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1159\/000358686","volume":"33","author":"B Yang","year":"2014","unstructured":"Yang B, Yang J, Bai J, Pu P, Liu J, Wang F, et al. Suv39h1 protects from myocardial ischemia-reperfusion injury in diabetic rats. Cell Physiol Biochem. 2014;33(4):1176\u201385.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10820_CR193","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.1038\/s41467-018-07173-2","volume":"9","author":"QJ Zhang","year":"2018","unstructured":"Zhang QJ, Tran TAT, Wang M, Ranek MJ, Kokkonen-Simon KM, Gao J, et al. Histone lysine dimethyl-demethylase KDM3A controls pathological cardiac hypertrophy and fibrosis. Nat Commun. 2018;9(1):5230.","journal-title":"Nat Commun"},{"issue":"13","key":"10820_CR194","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1039\/C6CC09882G","volume":"53","author":"B Cascella","year":"2017","unstructured":"Cascella B, Lee SG, Singh S. The small molecule JIB-04 disrupts O(2) binding in the Fe-dependent histone demethylase KDM4A\/JMJD2A. Chem Commun (Camb). 2017;53(13):2174\u20137.","journal-title":"Chem Commun (Camb)"},{"issue":"1","key":"10820_CR195","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.1038\/s41598-018-24903-0","volume":"8","author":"MS Kim","year":"2018","unstructured":"Kim MS, Cho HI, Yoon HJ, Ahn YH, Park EJ, Jin YH, et al. JIB-04, A Small Molecule Histone Demethylase Inhibitor, Selectively Targets Colorectal Cancer Stem Cells by Inhibiting the Wnt\/\u03b2-Catenin Signaling Pathway. Sci Rep. 2018;8(1):6611.","journal-title":"Sci Rep"},{"issue":"3","key":"10820_CR196","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.yjmcc.2006.10.018","volume":"42","author":"SV Penumathsa","year":"2007","unstructured":"Penumathsa SV, Thirunavukkarasu M, Koneru S, Juhasz B, Zhan L, Pant R, et al. Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J Mol Cell Cardiol. 2007;42(3):508\u201316.","journal-title":"J Mol Cell Cardiol"},{"issue":"14","key":"10820_CR197","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1093\/nar\/gkw301","volume":"44","author":"Y Wang","year":"2016","unstructured":"Wang Y, Li Y, Guo C, Lu Q, Wang W, Jia Z, et al. ISL1 and JMJD3 synergistically control cardiac differentiation of embryonic stem cells. Nucleic Acids Res. 2016;44(14):6741\u201355.","journal-title":"Nucleic Acids Res"},{"key":"10820_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2018.05.009","volume":"477","author":"Z Guo","year":"2018","unstructured":"Guo Z, Lu J, Li J, Wang P, Li Z, Zhong Y, et al. JMJD3 inhibition protects against isoproterenol-induced cardiac hypertrophy by suppressing \u03b2-MHC expression. Mol Cell Endocrinol. 2018;477:1\u201314.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10820_CR199","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3892\/ijmm.2015.2393","volume":"37","author":"Q Hu","year":"2016","unstructured":"Hu Q, Chen J, Zhang J, Xu C, Yang S, Jiang H. IOX1, a JMJD2A inhibitor, suppresses the proliferation and migration of vascular smooth muscle cells induced by angiotensin II by regulating the expression of cell cycle-related proteins. Int J Mol Med. 2016;37(1):189\u201396.","journal-title":"Int J Mol Med"},{"key":"10820_CR200","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.yjmcc.2014.03.005","volume":"72","author":"SE Aune","year":"2014","unstructured":"Aune SE, Herr DJ, Mani SK, Menick DR. Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion. J Mol Cell Cardiol. 2014;72:138\u201345.","journal-title":"J Mol Cell Cardiol"},{"key":"10820_CR201","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.yjmcc.2017.12.004","volume":"114","author":"DJ Herr","year":"2018","unstructured":"Herr DJ, Baarine M, Aune SE, Li X, Ball LE, Lemasters JJ, et al. HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury. J Mol Cell Cardiol. 2018;114:309\u201319.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10820_CR202","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.yexcr.2014.09.031","volume":"330","author":"AR Tiernan","year":"2015","unstructured":"Tiernan AR, Champion JA, Sambanis A. Trichostatin A affects the secretion pathways of beta and intestinal endocrine cells. Exp Cell Res. 2015;330(1):212\u201321.","journal-title":"Exp Cell Res"},{"issue":"1","key":"10820_CR203","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1124\/jpet.111.189910","volume":"341","author":"L Zhang","year":"2012","unstructured":"Zhang L, Qin X, Zhao Y, Fast L, Zhuang S, Liu P, et al. Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis. J Pharmacol Exp Ther. 2012;341(1):285\u201393.","journal-title":"J Pharmacol Exp Ther"},{"key":"10820_CR204","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2020.07.031","volume":"159","author":"X Guo","year":"2020","unstructured":"Guo X, Hong S, He H, Zeng Y, Chen Y, Mo X, et al. NF\u03baB promotes oxidative stress-induced necrosis and ischemia\/reperfusion injury by inhibiting Nrf2-ARE pathway. Free Radic Biol Med. 2020;159:125\u201335.","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"10820_CR205","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbamcr.2010.04.007","volume":"1803","author":"TC Zhao","year":"2010","unstructured":"Zhao TC, Zhang LX, Cheng G, Liu JT. gp-91 mediates histone deacetylase inhibition-induced cardioprotection. Biochim Biophys Acta. 2010;1803(7):872\u201380.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10820_CR206","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1159\/000493672","volume":"49","author":"Y Wang","year":"2018","unstructured":"Wang Y, Chen P, Wang L, Zhao J, Zhong Z, Wang Y, et al. Inhibition of Histone Deacetylases Prevents Cardiac Remodeling After Myocardial Infarction by Restoring Autophagosome Processing in Cardiac Fibroblasts. Cell Physiol Biochem. 2018;49(5):1999\u20132011.","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"10820_CR207","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.arcmed.2012.04.007","volume":"43","author":"L Yu","year":"2012","unstructured":"Yu L, Lu M, Wang P, Chen X. Trichostatin A ameliorates myocardial ischemia\/reperfusion injury through inhibition of endoplasmic reticulum stress-induced apoptosis. Arch Med Res. 2012;43(3):190\u20136.","journal-title":"Arch Med Res"},{"issue":"10","key":"10820_CR208","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1161\/CIRCULATIONAHA.113.002416","volume":"129","author":"M Xie","year":"2014","unstructured":"Xie M, Kong Y, Tan W, May H, Battiprolu PK, Pedrozo Z, et al. Histone deacetylase inhibition blunts ischemia\/reperfusion injury by inducing cardiomyocyte autophagy. Circulation. 2014;129(10):1139\u201351.","journal-title":"Circulation"},{"issue":"2","key":"10820_CR209","doi-asserted-by":"publisher","first-page":"H968","DOI":"10.1152\/ajpheart.00891.2006","volume":"293","author":"TM Lee","year":"2007","unstructured":"Lee TM, Lin MS, Chang NC. Inhibition of histone deacetylase on ventricular remodeling in infarcted rats. Am J Physiol Heart Circ Physiol. 2007;293(2):H968\u201377.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10820_CR210","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1248\/bpb.b18-00785","volume":"42","author":"S Nagata","year":"2019","unstructured":"Nagata S, Marunouchi T, Tanonaka K. Histone Deacetylase Inhibitor SAHA Treatment Prevents the Development of Heart Failure after Myocardial Infarction via an Induction of Heat-Shock Proteins in Rats. Biol Pharm Bull. 2019;42(3):453\u201361.","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10820_CR211","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc1779","volume":"6","author":"S Minucci","year":"2006","unstructured":"Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer. 2006;6(1):38\u201351.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10820_CR212","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.intimp.2013.06.027","volume":"17","author":"HM Zhong","year":"2013","unstructured":"Zhong HM, Ding QH, Chen WP, Luo RB. Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-\u03baB nuclear translocation. Int Immunopharmacol. 2013;17(2):329\u201335.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10820_CR213","doi-asserted-by":"publisher","first-page":"e2731","DOI":"10.1038\/cddis.2017.107","volume":"8","author":"X Liu","year":"2017","unstructured":"Liu X, Hu D, Zeng Z, Zhu W, Zhang N, Yu H, et al. SRT1720 promotes survival of aged human mesenchymal stem cells via FAIM: a pharmacological strategy to improve stem cell-based therapy for rat myocardial infarction. Cell Death Dis. 2017;8(4):e2731.","journal-title":"Cell Death Dis"},{"issue":"1","key":"10820_CR214","doi-asserted-by":"publisher","first-page":"e86977","DOI":"10.1371\/journal.pone.0086977","volume":"9","author":"M Shalwala","year":"2014","unstructured":"Shalwala M, Zhu SG, Das A, Salloum FN, Xi L, Kukreja RC. Sirtuin 1 (SIRT1) activation mediates sildenafil induced delayed cardioprotection against ischemia-reperfusion injury in mice. PLoS ONE. 2014;9(1):e86977.","journal-title":"PLoS ONE"},{"issue":"11","key":"10820_CR215","doi-asserted-by":"publisher","first-page":"H1558","DOI":"10.1152\/ajpheart.00865.2013","volume":"306","author":"S Koka","year":"2014","unstructured":"Koka S, Aluri HS, Xi L, Lesnefsky EJ, Kukreja RC. Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO\/SIRT1\/PGC-1\u03b1 signaling. Am J Physiol Heart Circ Physiol. 2014;306(11):H1558\u201368.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"10820_CR216","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1002\/jcp.29592","volume":"235","author":"F Akhondzadeh","year":"2020","unstructured":"Akhondzadeh F, Astani A. Resveratrol suppresses interleukin-6 expression through activation of sirtuin 1 in hypertrophied H9c2 cardiomyoblasts. J Cell Physiol. 2020;235(10):6969\u201377.","journal-title":"J Cell Physiol"},{"issue":"13","key":"10820_CR217","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1007\/s00018-012-0925-5","volume":"69","author":"M Becatti","year":"2012","unstructured":"Becatti M, Taddei N, Cecchi C, Nassi N, Nassi PA, Fiorillo C. SIRT1 modulates MAPK pathways in ischemic-reperfused cardiomyocytes. Cell Mol Life Sci. 2012;69(13):2245\u201360.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10820_CR218","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.mehy.2008.06.031","volume":"71","author":"L Tan","year":"2008","unstructured":"Tan L, Yu JT, Guan HS. Resveratrol exerts pharmacological preconditioning by activating PGC-1alpha. Med Hypotheses. 2008;71(5):664\u20137.","journal-title":"Med Hypotheses"},{"issue":"12","key":"10820_CR219","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1113\/jphysiol.2014.271387","volume":"592","author":"TK Sin","year":"2014","unstructured":"Sin TK, Yu AP, Yung BY, Yip SP, Chan LW, Wong CS, et al. Modulating effect of SIRT1 activation induced by resveratrol on Foxo1-associated apoptotic signalling in senescent heart. J Physiol. 2014;592(12):2535\u201348.","journal-title":"J Physiol"},{"issue":"422","key":"10820_CR220","doi-asserted-by":"publisher","first-page":"ra34","DOI":"10.1126\/scisignal.aad5736","volume":"9","author":"CR Morales","year":"2016","unstructured":"Morales CR, Li DL, Pedrozo Z, May HI, Jiang N, Kyrychenko V, et al. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression. Sci Signal. 2016;9(422):ra34.","journal-title":"Sci Signal"},{"issue":"31","key":"10820_CR221","doi-asserted-by":"publisher","first-page":"28930","DOI":"10.1074\/jbc.M303113200","volume":"278","author":"CL Antos","year":"2003","unstructured":"Antos CL, McKinsey TA, Dreitz M, Hollingsworth LM, Zhang CL, Schreiber K, et al. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem. 2003;278(31):28930\u20137.","journal-title":"J Biol Chem"},{"issue":"3","key":"10820_CR222","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/cvr\/cvn215","volume":"80","author":"P Gallo","year":"2008","unstructured":"Gallo P, Latronico MV, Gallo P, Grimaldi S, Borgia F, Todaro M, et al. Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure. Cardiovascular Res. 2008;80(3):416\u201324.","journal-title":"Cardiovascular Res"},{"issue":"3\u20134","key":"10820_CR223","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000438864","volume":"96","author":"B Lkhagva","year":"2015","unstructured":"Lkhagva B, Lin YK, Kao YH, Chazo TF, Chung CC, Chen SA, et al. Novel Histone Deacetylase Inhibitor Modulates Cardiac Peroxisome Proliferator-Activated Receptors and Inflammatory Cytokines in Heart Failure. Pharmacology. 2015;96(3\u20134):184\u201391.","journal-title":"Pharmacology"},{"key":"10820_CR224","doi-asserted-by":"publisher","unstructured":"Lee TI, Bai K-J, Chen YC, Lee TW, Chung C-C, Tsai WC, et al. Histone deacetylase inhibition of cardiac autophagy in rats on a high-fat diet with low-dose streptozotocin-induced type 2 diabetes mellitus. Mol Med Rep. 2017;17. https:\/\/doi.org\/10.3892\/mmr.2017.7905.","DOI":"10.3892\/mmr.2017.7905"},{"issue":"1","key":"10820_CR225","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1755-1536-7-10","volume":"7","author":"HF Nural-Guvener","year":"2014","unstructured":"Nural-Guvener HF, Zakharova L, Nimlos J, Popovic S, Mastroeni D, Gaballa MA. HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90\u2009+\u2009cardiac myofibroblast activation. Fibrogenesis tissue repair. 2014;7(1):10.","journal-title":"Fibrogenesis tissue repair"},{"issue":"5","key":"10820_CR226","doi-asserted-by":"publisher","first-page":"11482","DOI":"10.3390\/ijms160511482","volume":"16","author":"H Nural-Guvener","year":"2015","unstructured":"Nural-Guvener H, Zakharova L, Feehery L, Sljukic S, Gaballa M. Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6\/Stat3 Signaling in Ischemic Heart Failure. Int J Mol Sci. 2015;16(5):11482\u201399.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10820_CR227","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.celrep.2018.10.003","volume":"25","author":"T Wu","year":"2018","unstructured":"Wu T, Kamikawa YF, Donohoe ME. Brd4\u2019s Bromodomains Mediate Histone H3 Acetylation and Chromatin Remodeling in Pluripotent Cells through P300 and Brg1. Cell Rep. 2018;25(7):1756\u201371.","journal-title":"Cell Rep"},{"issue":"3","key":"10820_CR228","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cell.2013.07.013","volume":"154","author":"P Anand","year":"2013","unstructured":"Anand P, Brown JD, Lin CY, Qi J, Zhang R, Artero PC, et al. BET bromodomains mediate transcriptional pause release in heart failure. Cell. 2013;154(3):569\u201382.","journal-title":"Cell"},{"issue":"11","key":"10820_CR229","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3390\/cells12111461","volume":"12","author":"B Yan","year":"2023","unstructured":"Yan B, Gui Y, Guo Y, Sun J, Saifeddine M, Deng J, Hill JA, Hollenberg MD, Jiang ZS, Zheng XL. Impact of Short-Term (+)-JQ1 Exposure on Mouse Aorta: Unanticipated Inhibition of Smooth Muscle Contractility. Cells. 2023;12(11):1461.","journal-title":"Cells"},{"key":"10820_CR230","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ijcard.2017.01.005","volume":"232","author":"SJ Li","year":"2017","unstructured":"Li SJ, Kao YH, Chung CC, Chen WY, Cheng WL, Chen YJ. Activated p300 acetyltransferase activity modulates aortic valvular calcification with osteogenic transdifferentiation and downregulation of Klotho. Int J Cardiol. 2017;232:271\u20139.","journal-title":"Int J Cardiol"},{"issue":"49","key":"10820_CR231","doi-asserted-by":"publisher","first-page":"51163","DOI":"10.1074\/jbc.M409024200","volume":"279","author":"K Balasubramanyam","year":"2004","unstructured":"Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, et al. Curcumin, a novel p300\/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone\/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem. 2004;279(49):51163\u201371.","journal-title":"J Biol Chem"},{"issue":"11","key":"10820_CR232","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.numecd.2022.07.021","volume":"32","author":"V Musazadeh","year":"2022","unstructured":"Musazadeh V, Roshanravan N, Mohammadizadeh M, Kavyani Z, Dehghan P, Mosharkesh E. Curcumin as a novel approach in improving lipid profile: An umbrella meta-analysis. Nutr Metabolism Cardiovasc Dis. 2022;32(11):2493\u2013504.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"issue":"3","key":"10820_CR233","first-page":"868","volume":"118","author":"T Morimoto","year":"2008","unstructured":"Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Nagasawa A, et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Investig. 2008;118(3):868\u201378.","journal-title":"J Clin Investig"},{"issue":"8","key":"10820_CR234","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/CIRCRESAHA.123.322676","volume":"133","author":"S Serio","year":"2023","unstructured":"Serio S, Pagiatakis C, Musolino E, Felicetta A, Carullo P, Laura Frances J, et al. Cardiac Aging Is Promoted by Pseudohypoxia Increasing p300-Induced Glycolysis. Circul Res. 2023;133(8):687\u2013703.","journal-title":"Circul Res"},{"issue":"10","key":"10820_CR235","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1161\/CIRCRESAHA.118.314032","volume":"124","author":"J Guo","year":"2019","unstructured":"Guo J, Wang Z, Wu J, Liu M, Li M, Sun Y, et al. Endothelial SIRT6 Is Vital to Prevent Hypertension and Associated Cardiorenal Injury Through Targeting Nkx3.2-GATA5 Signaling. Circul Res. 2019;124(10):1448\u201361.","journal-title":"Circul Res"},{"key":"10820_CR236","doi-asserted-by":"publisher","unstructured":"Baran M, Miziak P. The role of Sirtuin 6 in the deacetylation of histone proteins as a factor in the progression of neoplastic disease. Int J Mol Sci. 2023;25(1). https:\/\/doi.org\/10.3390\/ijms25010497.","DOI":"10.3390\/ijms25010497"},{"key":"10820_CR237","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.abb.2019.06.010","volume":"670","author":"W Mian","year":"2019","unstructured":"Mian W, Zhang M, Ma Y, Liu F, Chen S, Lu J, et al. Chaetocin attenuates gout in mice through inhibiting HIF-1\u03b1 and NLRP3 inflammasome-dependent IL-1\u03b2 secretion in macrophages. Arch Biochem Biophys. 2019;670:94\u2013103.","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"10820_CR238","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s12265-022-10258-5","volume":"15","author":"MY Chen","year":"2022","unstructured":"Chen MY, Zhang ZH, Ke JF, Li TT, Li MF, Lu JX, et al. Chaetocin attenuates atherosclerosis progression and inhibits vascular smooth muscle cell phenotype switching. J Cardiovasc Transl Res. 2022;15(6):1270\u201382.","journal-title":"J Cardiovasc Transl Res"},{"key":"10820_CR239","doi-asserted-by":"publisher","first-page":"118412","DOI":"10.1016\/j.biopha.2025.118412","volume":"190","author":"R Yadav","year":"2025","unstructured":"Yadav R, Mishra S, Chaturvedi R, Pandey A. Therapeutic potential of curcumin in cardiovascular disease: Targeting atherosclerosis pathophysiology. Biomed Pharmacother. 2025;190:118412.","journal-title":"Biomed Pharmacother"},{"key":"10820_CR240","doi-asserted-by":"publisher","first-page":"109536","DOI":"10.1016\/j.bioorg.2026.109536","volume":"170","author":"B Li","year":"2026","unstructured":"Li B, Jiao L, Zhang Y. Pharmacological inhibition of histone Lactylation enhances immunotherapy efficacy in gastrointestinal cancers. Bioorg Chem. 2026;170:109536.","journal-title":"Bioorg Chem"},{"key":"10820_CR241","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.apsb.2023.09.003","volume":"14","author":"X Peng","year":"2024","unstructured":"Peng X, Hu Z, Zeng L, Zhang M, Xu C, Lu B, Tao C, Chen W, Hou W, Cheng K, Bi H, Pan W, Chen J. Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies. Acta Pharm Sin B. 2024;14:533.","journal-title":"Acta Pharm Sin B"},{"key":"10820_CR242","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/s41418-025-01620-6","volume":"33","author":"L Chen","year":"2026","unstructured":"Chen L, Zhang W, Chen H, Zhang Y, Guo B, Yang L, Yin C, Zuo Q, Ren L, Bai L, Wang R, Zhao S, Liu E, Wang W. HDAC3 activates endothelial NLRP3 inflammasome and promotes atherosclerosis via inhibiting the acetylation of specificity protein 1. Cell Death Differ. 2026;33:930.","journal-title":"Cell Death Differ"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-026-10820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-026-10820-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-026-10820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:02:25Z","timestamp":1787954545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-026-10820-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":242,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10820"],"URL":"https:\/\/doi.org\/10.1007\/s12265-026-10820-5","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"110"}}